These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32164984)

  • 1. Novel retinoic acid derivative induces differentiation and growth arrest in neuroblastoma.
    Marayati R; Williams AP; Bownes LV; Quinn CH; Stewart JE; Mroczek-Musulman E; Atigadda VR; Beierle EA
    J Pediatr Surg; 2020 Jun; 55(6):1072-1080. PubMed ID: 32164984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel second-generation rexinoid induces growth arrest and reduces cancer cell stemness in human neuroblastoma patient-derived xenografts.
    Marayati R; Bownes LV; Quinn CH; Wadhwani N; Williams AP; Markert HR; Atigadda V; Aye JM; Stewart JE; Yoon KJ; Beierle EA
    J Pediatr Surg; 2021 Jun; 56(6):1165-1173. PubMed ID: 33762121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma.
    Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
    Mol Cancer Ther; 2015 Jul; 14(7):1559-69. PubMed ID: 25944918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts.
    Marayati R; Bownes LV; Stafman LL; Williams AP; Quinn CH; Atigadda V; Aye JM; Stewart JE; Yoon KJ; Beierle EA
    Transl Oncol; 2021 Jan; 14(1):100893. PubMed ID: 33010553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.
    Garner EF; Stafman LL; Williams AP; Aye JM; Goolsby C; Atigadda VR; Moore BP; Nan L; Stewart JE; Hjelmeland AB; Friedman GK; Beierle EA
    J Neurooncol; 2018 Nov; 140(2):209-224. PubMed ID: 30132166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro.
    Williams AP; Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
    J Surg Res; 2018 Aug; 228():54-62. PubMed ID: 29907230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic Malignancies.
    Waters AM; Stewart JE; Atigadda VR; Mroczek-Musulman E; Muccio DD; Grubbs CJ; Beierle EA
    Mol Cancer Ther; 2016 May; 15(5):911-21. PubMed ID: 26873726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyngo-4a Induces Neuroblastoma Cell Differentiation Through The AKT and ERK1/2 Pathway.
    Huang J; Zhou Y; Zeng S; Xu J; Liu L; Grothusen J; Liu R
    CNS Neurol Disord Drug Targets; 2023; 22(10):1526-1534. PubMed ID: 36476431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.
    Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CP; Kogner P
    Med Pediatr Oncol; 2001 Jan; 36(1):127-31. PubMed ID: 11464864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional decreases in P2X7 receptors are associated with retinoic acid-induced neuronal differentiation of Neuro-2a neuroblastoma cells.
    Wu PY; Lin YC; Chang CL; Lu HT; Chin CH; Hsu TT; Chu D; Sun SH
    Cell Signal; 2009 Jun; 21(6):881-91. PubMed ID: 19385050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway.
    Sheikh A; Takatori A; Hossain MS; Hasan MK; Tagawa M; Nagase H; Nakagawara A
    Cancer Sci; 2016 Sep; 107(9):1223-32. PubMed ID: 27357360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Sirtuin 6 Induces Neuroblastoma Differentiation.
    Song HY; Rellinger EJ; Park SH; Paul P; Qiao J; Vasilopoulos A; Ozden O; Gius D; Chung DH
    Anticancer Res; 2018 Feb; 38(2):647-654. PubMed ID: 29374686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promyelocytic leukemia-nuclear body formation is an early event leading to retinoic acid-induced differentiation of neuroblastoma cells.
    Delaune A; Corbière C; Benjelloun FD; Legrand E; Vannier JP; Ripoll C; Vasse M
    J Neurochem; 2008 Jan; 104(1):89-99. PubMed ID: 17986232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor.
    Hämmerle B; Yañez Y; Palanca S; Cañete A; Burks DJ; Castel V; Font de Mora J
    PLoS One; 2013; 8(10):e76761. PubMed ID: 24116151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts.
    Williams AP; Garner EF; Stafman LL; Aye JM; Quinn CH; Marayati R; Stewart JE; Atigadda VR; Mroczek-Musulman E; Moore BP; Beierle EA; Friedman GK
    Transl Oncol; 2019 Oct; 12(10):1364-1374. PubMed ID: 31362265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
    Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
    Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
    Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
    Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex.
    Shi Q; Yu B; Zhang Y; Yang Y; Xu C; Zhang M; Chen G; Luo F; Sun B; Yang R; Li Y; Feng H
    Cell Oncol (Dordr); 2023 Dec; 46(6):1763-1775. PubMed ID: 37466744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.
    Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y
    J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced potency of 9-cis versus all-trans-retinoic acid to induce the differentiation of human neuroblastoma cells.
    Han G; Chang B; Connor MJ; Sidell N
    Differentiation; 1995 Jul; 59(1):61-9. PubMed ID: 7589896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.